Dec. 02, 2020
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation
Press Releases
-
-
News
Nov. 20, 2020WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou -
Collaboration
Nov. 09, 2020WuXi Biologics and AC Immune Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development -
Collaboration
Oct. 29, 2020WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa -
News
Oct. 08, 2020WuXi Biologics Unveils New Process Development and Testing Facility in King of Prussia, Pennsylvania -
Finance
Aug. 18, 2020WuXi Biologics Records Excellent Interim Results -
News
Aug. 06, 2020WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer -
Awards
Aug. 04, 2020WuXi Biologics Awarded as “Most Honored Company” by Institutional Investor -
Finance
Jun. 19, 2020Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?